crispr technology market share, crispr technology market, crispr technology market size, crispr technology market analysis, crispr technology market growth, global crispr technology market
How big is the crispr technology market today, and what are its future growth expectations?
The CRISPR technology market size has grown exponentially in recent years. It will grow from $2.05 billion in 2024 to $2.53 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. The growth in the historic period can be attributed to a rise in funding and an increase in pharmaceutical R&D expenditure.
The CRISPR technology market size is expected to see exponential growth in the next few years. It will grow to $5.75 billion in 2029 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to rising demand for gene therapeutics, technological advancements in the fields of genome editing, growing demand for the discovery of drugs, increasing demand for CRISPR in diagnostics, rising demand for CRISPR technologies in agriculture applications, and rising adoption of CRISPR technologies. Major trends in the forecast period include developing innovative next-generation technology, developing improved CRISPR technologies for better results in new drug developments, using AI to improve the efficiency and accuracy of gene editing with CRISPR, investing in new approaches such as IDMseq to increase accuracy, and establishing collaborations with companies.
Get Your Free Sample of The Global CRISPR Technology Market Report:
What have been the primary factors driving the crispr technology market’s growth?
The application of CRISPR technology as a diagnostic tool is expected to boost the market during this period. The Sherlock CRISPR SARS-CoV-2 kit is the first diagnostic kit based on CRISPR technology for infectious diseases caused due to COVID-19. In February 2021, FDA announced the emergency use authorization for Sherlock BioSciences Inc’s Sherlock CRISPR SARS-CoV-2 kit which is a CRISPR-based SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing) diagnostic test. This test helps in specifically targeting RNA or DNA sequences of the SARS-CoV-2 virus from specimens or samples such as nasal swabs from the upper respiratory tract and fluid in the lungs from bronchoalveolar lavage specimens. This diagnostic kit has high specificity and sensitivity and does not provide false negative or positive results. Widening the application of CRISPR technology for the diagnosis of infectious diseases will increase the demand for CRISPR technology products and services.
What are the key segments within the crispr technology market?
The CRISPR technology market covered in this report is segmented –
1) By Product Type: Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products
2) By Application: Biomedical, Agriculture, Diagnostics, Other Applications
3) By End-User: Academic Research Organizations, Biopharmaceutical Companies, Agricultural Biotechnology Companies, Contract Research Organizations (CROs)
Subsegments:
1) By Design Tools: CRISPR Design Software, sgRNA Design Tools, Bioinformatics Platforms
2) By Plasmid and Vector: Plasmid Vectors, Viral Vectors, Bacterial Vectors
3) By Cas9 and gRNA: Cas9 Proteins, Guide RNA (gRNA) Products, Cas9 Complexes
4) By Delivery System Products: Electroporation Systems, Lipid-Based Delivery Systems, Viral Delivery Systems, Nanoparticle-Based Delivery Systems
Order your report now for swift delivery
Which key players are shaping the crispr technology market?
Major companies operating in the CRISPR technology market include Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Horizon Discovery Group, Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.
How will emerging trends drive the crispr technology market throughout the forecast period?
Major companies operating in the CRISPR technology market are adopting a strategic partnership approach to provide treatment for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in November 2023, Vertex, a UK-based call center company, partnered with CRISPR Therapeutics., a Switzerland-based biotechnology company. With this partnership, they aim to develop innovative solutions and launched CRISPR/Cas9 Gene-Edited Therapy, CASGEVYTM. This CASGEVY (exagamglogene autotemcel) leverages CRISPR/Cas9 technology to edit genes in hematopoietic stem cells, enabling the production of functional hemoglobin, which can significantly reduce or eliminate painful vaso-occlusive crises associated with sickle cell disease and decrease the need for blood transfusions in patients with transfusion-dependent beta-thalassemia.
How do regional factors impact the crispr technology market, and which region is the largest contributor?
The countries covered in the CRISPR technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
What Does The CRISPR Technology Market Report 2025 Offer?
The crispr technology market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
CRISPR technology refers to a revolutionary gene-editing tool that enables precise modifications of DNA in living organisms. It is used to alter genes for various applications, including disease treatment, agricultural improvements, and biological research.
Purchase the exclusive report now to unlock valuable market insights:
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
Twitter: https://twitter.com/tbrc_info
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
